Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15664887 | 1.00 | PRKCA (0.32) | PRKCAPRKCE | |
| SCHEMBL15664548 | 0.94 | EPHX2 (0.31) | — | |
| SCHEMBL15664547 | 0.94 | EPHX2 (0.31) | — | |
| SCHEMBL15667724 | 0.90 | ZDHHC7 (0.30) | — | |
| SCHEMBL15679449 | 0.90 | ZDHHC7 (0.30) | — | |
| SCHEMBL15679445 | 0.88 | PRKCA (0.32) | PRKCAPRKCE | |
| SCHEMBL15664427 | 0.87 | — | — | |
| SCHEMBL15665051 | 0.84 | PRKCA (0.35) | PRKCAPRKCE | |
| SCHEMBL15665049 | 0.84 | PRKCA (0.35) | PRKCAPRKCE | |
| SCHEMBL15665047 | 0.84 | PRKCA (0.35) | PRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9945852-B2 | Method for determining the presence or absence of a biomarker | ARCIS BIOTECHNOLOGY HOLDINGS LIMITED (GB) | 2018-04-17 | — | — | US | disclosed |
| EP-2705367-B1 | METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF A BIOMARKER | BANGOR UNIV (GB) | 2017-04-26 | — | — | EP | disclosed |
| US-20140127709-A1 | METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF A BIOMARKER | BANGOR UNIVERSITY (GB) | 2014-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140127709-A1 | METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF A BIOMARKER | CA14, CD63, CA12 | PRKCA 4119/4885PRKCE 4056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.